News archive

Filter by: Reset

December 2020

- 15 December 2020
- Press Releases
GCAC Announces Commercial Launch of Medical Cannabis Efficacy App

Efixii platform connects cultivators to consumers while promoting product transparency.
- 1 December 2020
- Product News
GCAC Outlines Its Ethereum 2.0 Roadmap for Medical Cannabis

GCAC is focussed on delivering irrefutable truths using the Ethereum blockchain where it records the efficacy of medical cannabis treatments.

- 10 November 2020
- Press Releases
GCAC Enters into Definitive Agreement with Purity-IQ Biotechnology

This Agreement expands the GCAC Cultivator-SaaS license to allow cultivators to pay a “Purity-IQ Access Fee” to GCAC.
- 3 November 2020
- Press Releases
GCAC Strengthens Its Medical Cannabis Efficacy Platform with Purity-IQ Biotechnology to Address a $4.1 Billion Market...

Following on from its TraceLocker announcement on September 3rd, GCAC is attracting key players in the Canadian medical cannabis space.

- 29 October 2020
- Press Releases
GCAC Announces End-to-End SaaS Licensing for All Medical Cannabis Lifecycle Participants

These new SaaS licenses expand upon the current Cultivator-SaaS license to now include SaaS for independent laboratories, medical cannabis vendors and authorized retailers.
- 14 October 2020
- Press Releases
Citizen Green Medical Cannabis Data-Acquisition Platform Goes Live with the Signing of a 3-Year SaaS Licensing Deal

GCAC’s Cultivator Software-as-a-Service (“SaaS”) license enables growers’ staff to record all events for medical cannabis cultivations, including mother plant, laboratory tests, shipment and custom...

- 3 September 2020
- Press Releases
GCAC Announces Commercial Launch of its $5.92m Medical Cannabis Data-Acquisition Platform

Vancouver, British Columbia, Canada, September 3, 2020 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading commercial licensor of proprietar...

- 12 August 2020
- Press Releases
GCAC Announces Expansion of the Citizen Green Platform with New 3T (“Track-Trace-Treat”) Data Service for Medical Can...

Licensing the GCAC’s 3T data-acquisition service opens immediate revenue opportunities for the Company; starting from the earliest phase of a medical cannabis growers’ journey.

- 19 December 2019
- Press Releases
GCAC Files Patent Application for Cannabis on the Blockchain

The unique identifiers and cannabis data are stored in a plurality of data blocks of a blockchain, which are accessed by a cannabis processing server and processed to determine an end user treatment.

9 of 9